Filing Details

Accession Number:
0001181431-12-051916
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-24 18:14:13
Reporting Period:
2012-09-20
Filing Date:
2012-09-24
Accepted Time:
2012-09-24 18:14:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1030617 Ag Pharma Novartis Lichtstrasse 35
Basel Switzerland V8 CH 4002
No No Yes No
1114448 Ag Novartis Lichtstrasse 35
Basel Switzerland V8 CH 4002
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-20 1,551,896 $19.42 4,051,002 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities.